Combination High Dose Amrinone and Dopamine in the Management of Moribund Cardiogenic Shock After Open Heart Surgery
- 1 September 1988
- Vol. 94 (3) , 503-506
- https://doi.org/10.1378/chest.94.3.503
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Augmentation of Cardiac Function in End-Stage Heart Failure by Combined Use of Dobutamine and AmrinoneChest, 1986
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Intravenous amrinone in left ventricular failure complicated by acute myocardial infarctionThe American Journal of Cardiology, 1985
- Intravenous use of amrinone for the treatment of the failing heartThe American Journal of Cardiology, 1985
- Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure.Circulation, 1981
- Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failureThe American Journal of Cardiology, 1981
- Amrinone and exercise performance in patients with chronic heart failureThe American Journal of Cardiology, 1981
- Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.Circulation, 1980
- Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.Circulation, 1979
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978